Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
1.38M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
1.31M
-
Shares change
-
+442K
-
Total reported value, excl. options
-
$266K
-
Value change
-
-$141K
-
Number of buys
-
12
-
Number of sells
-
-5
-
Price
-
$0.20
Significant Holders of Applied DNA Sciences, Inc. - Common Stock, $0.001 par value (APDN) as of Q4 2024
27 filings reported holding APDN - Applied DNA Sciences, Inc. - Common Stock, $0.001 par value as of Q4 2024.
Applied DNA Sciences, Inc. - Common Stock, $0.001 par value (APDN) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.31M shares
of 1.38M outstanding shares and own 94.85% of the company stock.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (417K shares), Connective Capital Management, LLC (179K shares), MILLENNIUM MANAGEMENT LLC (135K shares), SBI Securities Co., Ltd. (117K shares), HRT FINANCIAL LP (101K shares), TWO SIGMA SECURITIES, LLC (98K shares), CITIGROUP INC (83.5K shares), TWO SIGMA INVESTMENTS, LP (62.5K shares), JANE STREET GROUP, LLC (22.1K shares), and Atria Wealth Solutions, Inc. (20K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.